Levetiracetam in the treatment of paroxysmal kinesiogenic choreoathetosis
暂无分享,去创建一个
[1] H. Przuntek,et al. Therapeutic aspects of kinesiogenic paroxysmal choreoathetosis and familial paroxysmal choreoathetosis of the Mount and Reback type , 2004, Journal of Neurology.
[2] S. Fahn,et al. A pilot tolerability and efficacy study of levetiracetam in patients with chronic myoclonus , 2001, Neurology.
[3] K. Bhatia,et al. Familial (Idiopathic) Paroxysmal Dyskinesias: An Update , 2001, Seminars in neurology.
[4] D. Margineanu,et al. Inhibition of neuronal hypersynchrony in vitro differentiates levetiracetam from classical antiepileptic drugs. , 2000, Pharmacological research.
[5] G. Plosker,et al. Levetiracetam. A review of its adjunctive use in the management of partial onset seizures. , 2000, Drugs.
[6] K. Jain. An assessment of levetiracetam as an anti-epileptic drug , 2000, Expert opinion on investigational drugs.
[7] F. Dubeau,et al. Exquisite sensitivity of paroxysmal kinesigenic choreoathetosis to carbamazepine , 1996, Neurology.
[8] J. Hénichart,et al. The novel antiepileptic drug levetiracetam (ucb L059) appears to act via a specific binding site in CNS membranes. , 1995, European journal of pharmacology.
[9] M. Kato,et al. Paroxysmal Kinesigenic Choreoathetosis: Report of a Case Relieved by Carbamazepine , 1969 .
[10] A. Kertesz. Paroxysmal kinesigenic choreoathetosis , 1967, Neurology.
[11] L. Mount,et al. FAMILIAL PAROXYSMAL CHOREOATHETOSIS: Preliminary Report on a Hitherto Undescribed Clinical Syndrome , 1940 .